Biogen is a corporate investor based in Cambridge, United States, founded in 1978. Verified contact details, AUM data, and investment preferences on FindLPs.
Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes.
Investment types: Early Stage, Early Stage: Seed, Early Stage: Start-up, Expansion / Late Stage, Venture (General)
Sectors & themes: Biotechnology, Healthcare, Healthcare Specialists, Pharmaceuticals
Preferred geographies: Europe, North America, OECD
Location: 225 Binney Street
FindLPs holds verified direct email addresses and phone numbers for decision-makers at Biogen. Contact details are masked on the free plan — start a plan to unlock full access and CSV export.
Unlock Contact DetailsSearch 25,850 limited partners with verified contact details.
LP firm data compiled from public regulatory filings (SEC Form ADV, FCA, AIFMD disclosures), company websites and press releases, LinkedIn public profiles, and verified outbound email testing. AUM figures reflect self-reported values from filings and may lag by 1–2 fiscal quarters; bands are normalized in USD. We do not publish personal residential information; firms or individuals may request removal at /contact. Methodology & sources · Updated July 2026.